摘要
目的为评价Cyfra21-1对癌性胸液的诊断价值。方法采用ELISA方法测定30例结核性胸液和30例癌性胸液患者胸液中的Cyfra21-1含量。结果Cyfra21-1临界值为≤14.23ng/ml。当特异性为90%时,诊断癌性胸液的敏感性73.33%。结论胸液Cyfra21-1的检测对癌性胸腔积液的鉴别诊断有着重要的意义。
Objective To investigate whether cytokeratin solution 19 fragment CYFRA211 is
useful for the differential diagnosis of malignant and benign pleural effusions. Methods The
concentration of Cyfra211 in pleural effusion from 30 patients with tuberculous pleurisy and 30
patients with malignant pleurisy were measured by ELISA. Results When the concentrations of
CYFRA 211 in pleural fluid was 1423ng/ml.the sensitivity of pleural fluid CYFRA 211 for
diagnosis of malignant pleural effusion was 7333%,when the specificity was 90%. Conclusion
We conclude that the measurement of CYFRR 211 in pleural effusion may be useful for the
differential diagnosis of malignant and tuberculous pleural effusions.
出处
《临床内科杂志》
CAS
1999年第1期23-24,共2页
Journal of Clinical Internal Medicine